BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Activity
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

26 hedge funds and large institutions have $82.3M invested in Bellerophon Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+9
Holders Change %
+52.94%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
12
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EI
1
EAM Investors
California
$614K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$2.39M
3
Bank of New York Mellon
3
Bank of New York Mellon
New York
$458K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.92M
5
TI
5
Telemetry Investments
New York
$205K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$2.08M
2
Wells Fargo
2
Wells Fargo
California
$0
3
Millennium Management
3
Millennium Management
New York
$0
4
LPL Financial
4
LPL Financial
California
$162K
5
Northern Trust
5
Northern Trust
Illinois
$153K
Name Holding Trade Value Shares
Change 		Shares
Change %
AG
26
Advisor Group
Arizona
$1K +$1K +18 New
Wells Fargo
27
Wells Fargo
California
– -$28K -1,333 Closed
Millennium Management
28
Millennium Management
New York
– -$18K -860 Closed
1
2